Lost your password?

Blogs about: Cetuximab

Featured Blog

Adjacent gene tops HER2 in judging anthracycline benefit in breast cancer

smnewsletters wrote 6 months ago: According to the bulk of the data, alterations in TOP2A—not HER2—are “the important predictive … more →

Tags: Cancer, breast cancer, colorectal, breast, colorectal cancer, HER2, TOP2A, Anthracyclines, Adjuvant chemotherapy

Three-year-old asks Gordon Brown for anti-cancer drug to save his father

calvininjax wrote 10 months ago: By Calvin Palmer A three-year-old boy has written to British Prime Minister Gordon Brown pleading fo … more →

Tags: News, health, united kingdom, gordon brown, Eddie Blades, Paul Blades, Erbitux, Harmby, North Yorkshire

Erbitux (Cetuximab) in First-Line Treatment Colorectal Cancer Mangement1 comment

bmirtsching wrote 1 year ago: CORT has conducted research and treatment studies with the monoclonal anti-EGFR (anti-epidermal grow … more →

Tags: colorectal cancer, bevacizumab, Avastin, Erbitux, Oxaliplatin, Irinotecan, Colon Cancer, Metastatic Colon Cancer, FOLFOX

Erbitux plus Irinotecan effective in Colorectal cancer

crimsoncanary wrote 1 year ago: Newly publsihed data from the MABEL study shows Erbitux plus Irinotecan is effective in Colorectal c … more →

Tags: Erbitux, bms, ImClone, HER1, Merck Serono, Lilly, Merck KGaA

Lilly to acquire ImClone

crimsoncanary wrote 1 year ago: Eli Lilly has announced that it will acquire ImClone Systems through an all cash tender offer of $70 … more →

Tags: kinase, Erbitux, bms, ImClone, HER1, Merck Serono, acquisition, Lilly, Merck KGaA

5 year data in Head and Neck cancer shows erbitux increases overall survival

crimsoncanary wrote 1 year ago: Five year data presented at the American Society for Therapeutic Radiology and Oncology (ASTRO) Meet … more →

Tags: Erbitux, bms, ImClone, HER1, Merck Serono, Merck KGaA

Erbitux now available in Japan for Advanced Colorectal Cancer

crimsoncanary wrote 1 year ago: ImClone Systems have announced that erbitux (cetuximab) has been commercially launched in Japan for … more →

Tags: Erbitux, bms, ImClone, HER1, Merck Serono, Merck KGaA

Erbitux continues to be effective in metastatic colorectal cancer

crimsoncanary wrote 1 year ago: Data presented at the European of Medical Oncology (ESMO) show that Erbitux, plus FOLFIRI, continued … more →

Tags: Erbitux, bms, ImClone, HER1, Merck Serono, Merck KGaA

Merck Serono submit Erbitux for NSCLC in Europe

crimsoncanary wrote 1 year ago: Merck Serono has submitted an EMEA application for Erbitux (cetuximab) for use in the firstline trea … more →

Tags: Erbitux, bms, ImClone, HER1, Merck Serono, Regulatory, Merck KGaA

Erbitux improves first line Head and Neck Cancer Survival (NEJM)

crimsoncanary wrote 1 year ago: Imclone and BMS have announced the publication of  Phase III results of Erbitux (cetuximab) plus pla … more →

Tags: Erbitux, bms, ImClone, HER1, Merck Serono, Merck KGaA

ImClone submit sBLA for Erbitux in First-Line Head and Neck Cancer

crimsoncanary wrote 1 year ago: ImClone Systems has submitted an sBLA to the US FDA to broaden the use of ERBITUX (cetuximab) to inc … more →

Tags: Erbitux, bms, ImClone, HER1, Merck Serono, Merck KGaA

Erbitux plus Taxane/Carboplatin effective in NSCLC

crimsoncanary wrote 1 year ago: ImClone have announced that Phase III results show erbitux (cetuximab) in combination with a taxane … more →

Tags: kinase, Erbitux, bms, ImClone, HER1, Merck Serono, Merck KGaA

Merck Serono receive EU approval for Erbitux in Metastatic Colorectal Cancer

crimsoncanary wrote 1 year ago: Merck Serono have received EU approval for Erbitux in EGFR expressing, KRAS wild-type metastatic col … more →

Tags: Kinase receptor, Erbitux, bms, ImClone, HER1, Merck Serono, Regulatory, approval, Merck KGaA

Erbitux approved in Japan for Advanced Colorectal Cancer

crimsoncanary wrote 1 year ago: ImClone Systems have announced that Erbitux (cetuximab) has been approved in Japan for use in treati … more →

Tags: Kinase receptor, Erbitux, bms, ImClone, HER1, Merck Serono, Regulatory, approval, Merck KGaA

Merck-Serono initiate Phase III trial of Erbitux in Gastric Cancer

crimsoncanary wrote 1 year ago: Merck KGaA (Merck-Serono) has initiated a Phase III study of Erbitux in combination with Xeloda and … more →

Tags: Erbitux, bms, ImClone, HER1, Merck Serono, Merck KGaA

NICE terminate review of Avastin/Erbitux regimens due to lack of data

crimsoncanary wrote 1 year ago: The UK NICE have announced that review of Avastin and Erbitux for the following indications have bee … more →

Tags: kinase, Erbitux, Avastin, bevacizumab, Nice, Guidance

Merck Serono submit EU application for Erbitux in Head and Neck Cancer

crimsoncanary wrote 1 year ago: Merck Serono have submitted a EU application for Erbitux (cetuximab) to be used as a first line trea … more →

Tags: kinase, Erbitux, bms, ImClone, HER1, Merck Serono

Evolving Chemotherapy for Advanced and Metastatic Gastric Cancer1 comment

bmirtsching wrote 1 year ago: Gastric cancer is the fourth most common cancer worldwide, and the second leading cause of death wor … more →

Tags: Gastric Cancer, Avastin, docetaxel, taxotere, cisplatin, Platinol, 5-FU, stomach cancer, 5-fluorouracil

Metastatic Lung Cancer Survival Improved by the Addition of Cetuximab to Chemotherapy: FLEX Study4 comments

bmirtsching wrote 1 year ago: The results of the FLEX study of cisplatin + vinorelbine (Navelbine) with or without cetuximab (Erbi … more →

Tags: lung cancer, bevacizumab, Avastin, metastatic lung cancer, Erbitux, Stage IV, Stage IIIb, FLEX Study, EGFR Inhibitors


Have your say. Start a blog.

See our free features →

Related Tags
All →

Follow this tag via RSS